Frank Stokes insider trades

Open-market stock purchases and sales by Frank Stokes, Director at Exagen Inc, from SEC Form 4 filings since Dec 13, 2019.

Recent trades

DateStockTradeValue
Jun 9, 2026XGN Exagen IncBought (not open market)—
Mar 5, 2026CSTL Castle Biosciences IncSold$168K
Mar 4, 2026CSTL Castle Biosciences IncBought (not open market)—
Mar 4, 2026CSTL Castle Biosciences IncBought (not open market)—
Mar 4, 2026CSTL Castle Biosciences IncBought (not open market)—
Mar 4, 2026CSTL Castle Biosciences IncBought (not open market)—
Mar 4, 2026CSTL Castle Biosciences IncSold (not open market)$302K
Mar 3, 2026CSTL Castle Biosciences IncSold$145K
Mar 3, 2026CSTL Castle Biosciences IncBought (not open market)—
Mar 3, 2026CSTL Castle Biosciences IncSold$47.3K
Mar 3, 2026CSTL Castle Biosciences IncSold (not open market)$99.6K
Jan 12, 2026CSTL Castle Biosciences IncBought (not open market)—
Dec 11, 2025CSTL Castle Biosciences IncSold$168K
Dec 10, 2025CSTL Castle Biosciences IncBought (not open market)—
Dec 10, 2025CSTL Castle Biosciences IncSold (not open market)$105K
Dec 9, 2025CSTL Castle Biosciences IncSold (not open market)$250K
Dec 9, 2025CSTL Castle Biosciences IncBought (not open market)—
Nov 11, 2025CSTL Castle Biosciences IncSold$189K

Companies traded

  • XGN Exagen Inc: other filings, last Jun 9, 2026
  • CSTL Castle Biosciences Inc: 33 sales, last Mar 5, 2026

Get free alerts when Frank Stokes files a new trade →